Having your sight slowly taken from you is traumatic. Getting it back can feel like nothing short of a miracle. In developed nations, age-related macular degeneration is the leading cause of blindness among our aging population. Currently over 2.2 million Americans suffer from age-related macular degeneration. Physicians and researchers at the University of Colorado Anschutz Medical Campus are exploring how stem cells and gene therapies can halt and even reverse loss of sight from macular degeneration, as well as many other causes of blindness.
Happening Right Now at CU Anschutz
Dr. Naresh Mandava, Professor and Chair, Department of Ophthalmology & Executive Director, University of Colorado Eye Center
Dr. Naresh Mandava is a specialist in the medical and surgical management of retinal diseases. He is widely regarded as one of the world’s foremost experts on age-related macular degeneration. The Colorado Eye Center, which Dr.Mandava oversees at the CU Anschutz Medical Campus, is currently participating in multiple clinical trials, including treatments for macular degeneration.
Dr. Mandava is betting on the promise of restoring vision for those who are afflicted with macular degeneration through gene therapy and stem cell technology. By bringing together a multidisciplinary team of physicians, pharmacists, scientists and engineers, and using 3D printing techniques to accelerate prototyping, Dr. Mandava and his team have created a facility with the most up-to-date specialized equipment for retinal surgery.
Mandava has treated thousands of patients suffering from macular degeneration and helped to halt and even reverse the progress of the disease, but he believes he can do more. Through his ongoing efforts, Dr. Naresh believes that within the next ten years, breakthroughs in regenerative medicine may ultimately give us the ability to restore sight for those with macular degeneration.